Mission Statement
Bridge Resources shall Help control and eventually eradicate Malaria and Hepatitis B from our society and to bring awareness of the dangers of Hepatitis B and its effects on society and development.
Aims and Objectives
• The initial focus of the Malaria Control Program is to assist Ghana’s Ministry of Health in its goal to protect all 22 million Ghanaians at-risk from malaria through free distribution of long-lasting insecticide bed net. By purchasing the balance of nets needed by the national program and by co-ordinating net distribution and health education on malaria in the various districts and communities, we hope to achieve every agreed target with the Ministry.
• Organize clean up campaigns to reduce and eliminate breeding grounds of Mosquitoes.
• Educate communities on the importance of cleanliness and its effect on Malaria control
• In addition to long-lasting insecticidal bed net distribution, the organisation will work with other partners to assist with health education and evaluation of the national program to help prevent Hepatitis B and provide treatment for malaria.
• Provide Vaccines and drugs to Help eliminate Malaria and Control Hepatitis B
• Provide counseling services to Individuals of various communities in relation to Hepatitis B treatment.
• Liaise with the District Health Authorities and organize insecticide spraying programmes within the communities.
• Ensure that 70% of Ghanaian populace is tested for Hepatitis B and immunized against it by 2015.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close